Abstract: The present invention relates to polythioamides having their thioamide repeating units at least partly positioned in sidechains of the polymer, to a method for preparing such polymers, as well as to suitable applications of such polymers.

Abstract: Block copolymers have a general chemical structure of one of the formulas [A]n-[B]m and [B]n-[A]m, wherein block [A] is a poly(2-oxazine) and wherein block [B] is a poly(2-oxazoline). The block copolymers have desired thermogelling and rheological properties and are useful as carrier materials for active ingredients such as drugs, cells, proteins, and other active ingredients.

Abstract: Provided is a block copolymer comprising a polymer block (A) formed from repeating units of formula (I): wherein R1 is methyl or ethyl, and a polymer block (B) formed from repeating units of formula (II): as well as a hydrogel comprising the block copolymer.

Abstract: Provided is a block copolymer comprising a polymer block (A) which comprises repeating units of formula (I) and a polymer block (B) which comprises repeating units of formula (II), wherein R1 is methyl or ethyl, and R2 represents a group —CH2—CH2-phenyl. The copolymer of the present invention allows a rapid thermoresponsive inverse gelation to be achieved, yielding a hydrogel with viscoelastic solid-like properties, as well as shear thinning, rapid structure recovery and good strain resistance properties. The hydrogel can be favorably used in 3D printing applications.

Abstract: Provided is an (A)-(B)-(A) triblock copolymer comprising two hydrophilic polymer blocks (A) as further defined herein, and a polymer block (B), said polymer block (B) comprising at least one type of repeating unit of the following formula (I) wherein R1 is an aliphatic hydrocarbon group which is optionally substituted with one or more of —OR5, —SR5, —NR6R7, —(NR6R7R8)+, —CONR6R7, —C(O)OR9 and —C(O)R10, wherein R5 to R10 are independently selected from H, aliphatic and aromatic residues, and wherein R1 is selected such that the polymer block (B) is more hydrophobic than the polymer block (A); and compositions, such as pharmaceutical compositions, formed with the block copolymer.

Abstract: Provided is a block copolymer comprising a polymer block (A) formed from repeating units of formula (I): wherein R1 is methyl or ethyl, and a polymer block (B) formed from repeating units of formula (II): as well as a hydrogel comprising the block copolymer.

Abstract: Block copolymers have a general chemical structure of one of the formulas [A]n-[B]m and [B]n-[A]m, wherein block [A] is a poly(2-oxazine) and wherein block [B] is a poly(2-oxazoline). The block copolymers have desired thermogelling and rheological properties and are useful as carrier materials for active ingredients such as drugs, cells, proteins, and other active ingredients.

Abstract: Provided is an (A)-(B)-(A) triblock copolymer comprising two hydrophilic polymer blocks (A) as further defined herein, and a polymer block (B), said polymer block (B) comprising at least one type of repeating unit of the following formula (I) wherein R1 is an aliphatic hydrocarbon group which is optionally substituted with one or more of —OR5, —SR5, —NR6R7, —(NR6R7R8)+, —CONR6R7, —C(O)OR9 and —C(O)R10, wherein R5 to R10 are independently selected from H, aliphatic and aromatic residues, and wherein R1 is selected such that the polymer block (B) is more hydrophobic than the polymer block (A); and compositions, such as pharmaceutical compositions, formed with the block copolymer.

Abstract: Provided is a block copolymer comprising a polymer block (A) formed from repeating units of formula (I): wherein R1 is methyl or ethyl, and a polymer block (B) formed from repeating units of formula (II): as well as a hydrogel comprising the block copolymer.

Abstract: Block copolymers have a general chemical structure of one of the formulas [A]n-[B]m and [B]n-[A]m, wherein [A] is a poly(2-oxazine) and wherein [B] is a poly(2-oxazoline). The block copolymers have desired thermogelling and rheological properties and are useful as carrier materials for active ingredients such as drugs, cells, proteins, and other active ingredients.

Abstract: The present invention provides polymer aggregates as delivery vehicles for therapeutics and diagnostics. The present invention additionally provides methods of synthesis and uses for such aggregates.

Abstract: The present invention provides polymer aggregates as delivery vehicles for therapeutics and diagnostics. The present invention additionally provides methods of synthesis and uses for such aggregates.

Abstract: The present invention provides polymer aggregates as delivery vehicles for therapeutics and diagnostics. The present invention additionally provides methods of synthesis and uses for such aggregates.